Nkarta, Inc. Increase Decrease In Operating Lease Liability
Nkarta, Inc. (NKTX) reported Increase Decrease In Operating Lease Liability of -$2.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-10
- Nkarta, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$1.46M.
- Nkarta, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$1.42M.
- Nkarta, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$1.37M.
- Nkarta, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$1.91M.
- Nkarta, Inc. increase decrease in operating lease liability for fiscal 2025 was -$5.01M.
- Nkarta, Inc. increase decrease in operating lease liability for fiscal 2024 was -$6.42M, a 228.68% decline from fiscal 2023.
- Nkarta, Inc. increase decrease in operating lease liability for fiscal 2023 was $4.99M, a 84.64% decline from fiscal 2022.
- Nkarta, Inc. increase decrease in operating lease liability for fiscal 2022 was $32.47M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 3 month as first filed | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 6 month as first filed | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$2.88M 10-Q · filed 2026-08-10 | -$4.25M derived: sum of 3 quarters · filed 2026-08-10 | -$6.16M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | -$1.42M 10-Q · filed 2026-05-12 | -$2.79M derived: sum of 2 quarters · filed 2026-05-12 | -$4.70M derived: sum of 3 quarters · filed 2026-05-12 | -$5.07M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$3.28M derived: sum of 2 quarters · filed 2026-03-25 | -$3.65M derived: sum of 3 quarters · filed 2026-08-10 | -$5.01M 10-K · filed 2026-03-25 | ||
| 2025-09-30 | -$1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.28M derived: sum of 2 quarters · filed 2026-08-10 | -$3.64M 10-Q · filed 2025-11-10 | -$6.59M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | -$369.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.73M 10-Q · filed 2026-08-10 | -$4.68M derived: sum of 3 quarters · filed 2026-08-10 | -$4.80M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | -$1.36M 10-Q · filed 2026-05-12 | -$4.31M derived: sum of 2 quarters · filed 2026-05-12 | -$4.43M derived: sum of 3 quarters · filed 2026-05-12 | -$6.61M derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | -$2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$3.07M derived: sum of 2 quarters · filed 2026-03-25 | -$5.25M derived: sum of 3 quarters · filed 2026-03-25 | -$6.42M 10-K · filed 2026-03-25 | ||
| 2024-09-30 | -$124.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.31M derived: sum of 2 quarters · filed 2025-11-10 | -$3.47M 10-Q · filed 2025-11-10 | -$4.59M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | -$2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$3.35M 10-Q · filed 2025-08-12 | -$4.47M derived: sum of 3 quarters · filed 2025-08-12 | -$5.50M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | -$1.16M 10-Q · filed 2025-05-14 | -$2.29M derived: sum of 2 quarters · filed 2025-05-14 | -$3.32M derived: sum of 3 quarters · filed 2025-05-14 | -$4.17M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$2.16M derived: sum of 2 quarters · filed 2025-03-26 | -$3.01M derived: sum of 3 quarters · filed 2025-03-26 | $4.99M 10-K · filed 2025-03-26 | ||
| 2023-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.88M derived: sum of 2 quarters · filed 2024-11-07 | $6.11M 10-Q · filed 2024-11-07 | $27.14M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | -$849.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $7.14M 10-Q · filed 2024-08-13 | $28.17M derived: sum of 3 quarters · filed 2024-08-13 | $35.96M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $7.99M 10-Q · filed 2024-05-09 | $29.02M derived: sum of 2 quarters · filed 2024-05-09 | $36.81M derived: sum of 3 quarters · filed 2024-05-09 | $38.85M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $21.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $28.82M derived: sum of 2 quarters · filed 2024-03-21 | $30.86M derived: sum of 3 quarters · filed 2024-03-21 | $32.47M 10-K · filed 2024-03-21 | ||
| 2022-09-30 | $7.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $9.83M derived: sum of 2 quarters · filed 2023-11-09 | $11.45M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | $2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $3.65M 10-Q · filed 2023-08-10 | $726.00K 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $1.61M 10-Q · filed 2023-05-11 | $295.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |